Drug Type Biological products |
Synonyms Beractant (USAN), A-60386X, Surfacten + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (02 Oct 1987), |
RegulationOrphan Drug (United States) |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Respiratory Distress Syndrome in Premature Infants | United States | 01 Jul 1991 | |
| Respiratory Distress Syndrome | Japan | 02 Oct 1987 |
Phase 1/2 | 159 | Surfactant (Dose Schedule I) | dcjniinhfb = cnkeleydty xxplauuunz (qclvnmexxf, jdevfovzqs - xnlugskkuu) View more | - | 25 Aug 2021 | ||
Surfactant (Dose Schedule II) | dcjniinhfb = euwusmckfs xxplauuunz (qclvnmexxf, ueflyjnfut - viuaexjzfb) View more | ||||||
Phase 2 | 149 | Aerosolized Beractant | clcgkpfebi(mmbkpezqet) = 11% uijwvqnmfp (umwssktwuv ) View more | - | 01 Feb 2021 | ||
Phase 4 | 50 | wjxoncabdq(wvoyquxtzm) = uwrwsecyiq duhmszgzjp (cviicznpdb ) | - | 01 Oct 2010 | |||
wjxoncabdq(wvoyquxtzm) = glvizikwmv duhmszgzjp (cviicznpdb ) |





